Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

Andrea Schuessler, Rajiv Khanna(QIMR Berghofer Medical Research Institute), Katherine Matthews, Kerenaftali Klein(QIMR Berghofer Medical Research Institute), Corey Smith(QIMR Berghofer Medical Research Institute), Tania Crough, Linda Jones, David Walker(St. Jude Children's Research Hospital), Hamish Alexander(Ankara Spine Center), Vijayendra Dasari(QIMR Berghofer Medical Research Institute), Glen M. Boyle(Queensland University of Technology), Leone Beagley, Amy Smalley(Wesley Hospital), Sweera Rehan(QIMR Berghofer Medical Research Institute)
Cancer Research
May 4, 2014
10.1158/0008-5472.can-14-0296
Cited by 181

Related Papers

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
|Nature|2011|474
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients
|Blood|2006|250
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
|Proceedings of the National Academy of Sciences|2004|235